Merck & Co., Inc.
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck Total Diabetes Franchise (Januvia + Janumet) by Year
Total Diabetes Franchise (Januvia + Janumet) — Worldwide sales ($M) ($M)
Merck Total Diabetes Franchise (Januvia + Janumet): $2,862M in FY2025, up 10.1% from a year earlier.
Where the FY2025 figure comes from
“Total Diabetes sales were $2,862 million and $2,599 million”
Source: Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗
Reported in Form 8-K Supplemental Table 3 Footnote (Total Diabetes sales).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Diabetes Franchise (Januvia + Janumet) — Worldwide sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2,862 | +10.1% | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| FY2024 | Dec 31, 2024 | 2,599 | -29.8% | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| FY2023 | Dec 31, 2023 | 3,701 | -23.7% | Form 8-K (tm255059d1_ex99-1.htm, filed 2025-02-04) ↗ |
| FY2022 | Dec 31, 2022 | 4,848 | -13.2% | Form 8-K (tm244517d1_ex99-1.htm, filed 2024-02-01) ↗ |
| FY2021 | Dec 31, 2021 | 5,584 | -0.1% | Form 8-K (tm222755d1_ex99-1.htm, filed 2022-02-03) ↗ |
| FY2020 | Dec 31, 2020 | 5,588 | -2.2% | Form 8-K (tm222755d1_ex99-1.htm, filed 2022-02-03) ↗ |
| FY2019 | Dec 31, 2019 | 5,714 | -4.7% | Form 8-K (tm206551d1_ex99-1.htm, filed 2020-02-05) ↗ |
| FY2018 | Dec 31, 2018 | 5,994 | +1.2% | Form 8-K (tm206551d1_ex99-1.htm, filed 2020-02-05) ↗ |
| FY2017 | Dec 31, 2017 | 5,922 | – | Form 8-K (a19-3795_1ex99d1.htm, filed 2019-02-01) ↗ |
Breakdown
What makes up total Diabetes Franchise (Januvia + Janumet)
Cite this data
StockData. (2026). Merck Total Diabetes Franchise (Januvia + Janumet) ($M), annual FY2017–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/rev-total-diabetes
See every metric in the Merck KPI table. Data updated Oct 26, 2026.